Mary Weiser-Evans
Concepts (421)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Smooth Muscle | 21 | 2023 | 236 | 4.530 |
Why?
| PTEN Phosphohydrolase | 13 | 2020 | 143 | 4.260 |
Why?
| Muscle, Smooth, Vascular | 25 | 2023 | 454 | 4.040 |
Why?
| Vascular Remodeling | 8 | 2022 | 152 | 3.010 |
Why?
| Atherosclerosis | 4 | 2023 | 345 | 2.510 |
Why?
| Plaque, Atherosclerotic | 2 | 2023 | 40 | 1.830 |
Why?
| Adventitia | 2 | 2022 | 39 | 1.430 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2020 | 56 | 1.330 |
Why?
| Fibrosis | 12 | 2023 | 483 | 1.200 |
Why?
| Stem Cells | 6 | 2023 | 559 | 1.190 |
Why?
| Lung Neoplasms | 19 | 2023 | 2220 | 1.120 |
Why?
| Vascular System Injuries | 3 | 2023 | 70 | 1.060 |
Why?
| Mice | 42 | 2023 | 15520 | 1.020 |
Why?
| Myofibroblasts | 2 | 2023 | 120 | 0.990 |
Why?
| Cell Proliferation | 18 | 2021 | 2275 | 0.990 |
Why?
| Neointima | 4 | 2022 | 12 | 0.920 |
Why?
| Hypercholesterolemia | 1 | 2023 | 93 | 0.890 |
Why?
| Spinocerebellar Ataxias | 1 | 2022 | 3 | 0.870 |
Why?
| Tunica Intima | 5 | 2010 | 78 | 0.870 |
Why?
| Animals | 62 | 2023 | 33381 | 0.860 |
Why?
| Galectin 3 | 1 | 2022 | 20 | 0.860 |
Why?
| Cell Differentiation | 10 | 2023 | 1753 | 0.810 |
Why?
| Heart-Assist Devices | 4 | 2022 | 485 | 0.790 |
Why?
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 13 | 0.760 |
Why?
| Serum Response Factor | 3 | 2016 | 31 | 0.720 |
Why?
| Carotid Artery Injuries | 5 | 2010 | 42 | 0.710 |
Why?
| Chemokine CXCL12 | 2 | 2011 | 80 | 0.700 |
Why?
| Coronary Restenosis | 1 | 2019 | 18 | 0.700 |
Why?
| Cyclin D1 | 1 | 2019 | 61 | 0.700 |
Why?
| Mice, Inbred C57BL | 21 | 2023 | 4908 | 0.700 |
Why?
| Coronary Vessels | 2 | 2018 | 233 | 0.690 |
Why?
| High-Throughput Screening Assays | 1 | 2020 | 122 | 0.670 |
Why?
| Tumor Microenvironment | 8 | 2021 | 454 | 0.620 |
Why?
| Arteries | 4 | 2022 | 250 | 0.610 |
Why?
| Vascular Diseases | 1 | 2019 | 241 | 0.580 |
Why?
| Rats | 20 | 2019 | 5392 | 0.570 |
Why?
| Mice, Knockout | 15 | 2021 | 2680 | 0.570 |
Why?
| Heparan Sulfate Proteoglycans | 4 | 2003 | 21 | 0.570 |
Why?
| Mice, Transgenic | 9 | 2020 | 2025 | 0.550 |
Why?
| PPAR gamma | 7 | 2019 | 188 | 0.530 |
Why?
| Cells, Cultured | 17 | 2021 | 4077 | 0.520 |
Why?
| Carcinoma, Non-Small-Cell Lung | 7 | 2023 | 968 | 0.520 |
Why?
| Gene Expression Regulation | 5 | 2019 | 2445 | 0.490 |
Why?
| Acute Kidney Injury | 5 | 2023 | 709 | 0.490 |
Why?
| Hypertension, Pulmonary | 5 | 2023 | 1794 | 0.480 |
Why?
| Cell Division | 8 | 2004 | 776 | 0.480 |
Why?
| Disease Models, Animal | 16 | 2023 | 3730 | 0.480 |
Why?
| Signal Transduction | 18 | 2019 | 4709 | 0.470 |
Why?
| Hypertension | 1 | 2022 | 1203 | 0.460 |
Why?
| Hyperplasia | 5 | 2020 | 170 | 0.460 |
Why?
| MicroRNAs | 2 | 2017 | 637 | 0.450 |
Why?
| Protein Kinases | 4 | 2014 | 310 | 0.430 |
Why?
| Bone Marrow Cells | 2 | 2011 | 273 | 0.400 |
Why?
| Transforming Growth Factor beta1 | 3 | 2023 | 164 | 0.400 |
Why?
| Ureteral Obstruction | 3 | 2021 | 59 | 0.380 |
Why?
| Cell Movement | 5 | 2012 | 896 | 0.380 |
Why?
| Kidney | 6 | 2021 | 1353 | 0.380 |
Why?
| Macrophages | 4 | 2021 | 1324 | 0.370 |
Why?
| Muscle, Smooth | 2 | 2023 | 157 | 0.370 |
Why?
| Autocrine Communication | 2 | 2014 | 42 | 0.350 |
Why?
| Phospholipases A2, Cytosolic | 1 | 2009 | 6 | 0.350 |
Why?
| Cell Dedifferentiation | 3 | 2016 | 30 | 0.340 |
Why?
| Angiotensin II | 3 | 2021 | 107 | 0.340 |
Why?
| Cisplatin | 3 | 2020 | 271 | 0.330 |
Why?
| Platelet-Derived Growth Factor | 4 | 2020 | 83 | 0.330 |
Why?
| Group IV Phospholipases A2 | 3 | 2017 | 46 | 0.330 |
Why?
| Male | 25 | 2023 | 57801 | 0.320 |
Why?
| Carcinoma, Lewis Lung | 2 | 2019 | 13 | 0.310 |
Why?
| Hypoxia | 2 | 2013 | 963 | 0.310 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2004 | 37 | 0.310 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 4 | 2019 | 26 | 0.310 |
Why?
| Heart Failure | 4 | 2023 | 1969 | 0.300 |
Why?
| Proteins | 2 | 2006 | 938 | 0.300 |
Why?
| Proto-Oncogene Proteins c-akt | 7 | 2014 | 420 | 0.300 |
Why?
| Nuclear Proteins | 2 | 2023 | 597 | 0.300 |
Why?
| Rats, Sprague-Dawley | 9 | 2016 | 2478 | 0.290 |
Why?
| Actins | 3 | 2018 | 404 | 0.290 |
Why?
| TOR Serine-Threonine Kinases | 5 | 2014 | 369 | 0.290 |
Why?
| Proto-Oncogene Proteins | 3 | 2004 | 618 | 0.280 |
Why?
| Acetyltransferases | 1 | 2006 | 21 | 0.280 |
Why?
| Adenocarcinoma | 5 | 2017 | 812 | 0.270 |
Why?
| Polycystic Kidney, Autosomal Dominant | 2 | 2019 | 209 | 0.270 |
Why?
| Endothelial Cells | 2 | 2022 | 732 | 0.270 |
Why?
| Inflammation | 4 | 2023 | 2566 | 0.270 |
Why?
| Protein-Tyrosine Kinases | 3 | 2003 | 407 | 0.260 |
Why?
| Embryonic Development | 1 | 2006 | 118 | 0.260 |
Why?
| RNA Interference | 5 | 2014 | 460 | 0.260 |
Why?
| Myeloid Cells | 2 | 2019 | 128 | 0.250 |
Why?
| Phosphatidylinositol 3-Kinases | 4 | 2010 | 341 | 0.250 |
Why?
| Humans | 32 | 2023 | 118974 | 0.250 |
Why?
| Ribosomal Protein S6 | 1 | 2004 | 14 | 0.250 |
Why?
| Gene Expression | 3 | 2014 | 1489 | 0.240 |
Why?
| Corn Oil | 1 | 2023 | 3 | 0.240 |
Why?
| Inflammation Mediators | 2 | 2021 | 502 | 0.240 |
Why?
| Receptors, LDL | 1 | 2023 | 40 | 0.240 |
Why?
| Azotemia | 1 | 2023 | 6 | 0.230 |
Why?
| Proprotein Convertase 9 | 1 | 2023 | 60 | 0.230 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2004 | 145 | 0.220 |
Why?
| Phosphorylation | 6 | 2019 | 1633 | 0.220 |
Why?
| Disease Progression | 7 | 2019 | 2490 | 0.220 |
Why?
| Lipoxygenase Inhibitors | 2 | 2021 | 36 | 0.220 |
Why?
| Rejuvenation | 1 | 2022 | 14 | 0.220 |
Why?
| Extracellular Matrix | 4 | 2021 | 446 | 0.220 |
Why?
| Phenotype | 9 | 2021 | 3003 | 0.210 |
Why?
| Polycystic Kidney Diseases | 2 | 2019 | 55 | 0.210 |
Why?
| Programmed Cell Death 1 Receptor | 3 | 2020 | 197 | 0.210 |
Why?
| DNA Helicases | 1 | 2023 | 131 | 0.210 |
Why?
| Zebrafish | 1 | 2006 | 434 | 0.210 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2021 | 13 | 0.210 |
Why?
| Arachidonate 15-Lipoxygenase | 1 | 2021 | 16 | 0.210 |
Why?
| Aortic Valve Insufficiency | 1 | 2022 | 42 | 0.210 |
Why?
| Cell Line, Tumor | 9 | 2019 | 2851 | 0.210 |
Why?
| Cytokines | 4 | 2021 | 1900 | 0.210 |
Why?
| Nephritis | 1 | 2021 | 30 | 0.210 |
Why?
| Cholesterol | 1 | 2023 | 373 | 0.200 |
Why?
| Assisted Circulation | 1 | 2021 | 24 | 0.200 |
Why?
| Dual-Specificity Phosphatases | 1 | 2021 | 10 | 0.200 |
Why?
| Metformin | 2 | 2023 | 295 | 0.200 |
Why?
| Adaptive Immunity | 2 | 2023 | 161 | 0.200 |
Why?
| Transcription Factors | 4 | 2023 | 1570 | 0.200 |
Why?
| Protein Kinase Inhibitors | 3 | 2023 | 811 | 0.200 |
Why?
| Promoter Regions, Genetic | 5 | 2020 | 1158 | 0.200 |
Why?
| Female | 16 | 2023 | 61565 | 0.190 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2017 | 984 | 0.190 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2021 | 146 | 0.190 |
Why?
| Ventricular Dysfunction, Right | 1 | 2023 | 228 | 0.190 |
Why?
| Aortic Diseases | 1 | 2021 | 94 | 0.190 |
Why?
| Homeostasis | 2 | 2022 | 594 | 0.190 |
Why?
| Wound Healing | 1 | 2022 | 270 | 0.180 |
Why?
| Antineoplastic Agents, Immunological | 2 | 2019 | 156 | 0.180 |
Why?
| Blotting, Western | 3 | 2019 | 1194 | 0.180 |
Why?
| Jugular Veins | 1 | 2020 | 47 | 0.180 |
Why?
| Intestines | 1 | 2023 | 332 | 0.180 |
Why?
| Crohn Disease | 1 | 2023 | 197 | 0.180 |
Why?
| Myocytes, Cardiac | 2 | 2014 | 472 | 0.180 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 116 | 0.180 |
Why?
| Arachidonate 5-Lipoxygenase | 2 | 2019 | 45 | 0.180 |
Why?
| GATA4 Transcription Factor | 1 | 2019 | 18 | 0.180 |
Why?
| Kidney Tubules | 2 | 2019 | 128 | 0.170 |
Why?
| Chromatin | 1 | 2023 | 441 | 0.170 |
Why?
| Azacitidine | 1 | 2020 | 119 | 0.170 |
Why?
| Wnt Signaling Pathway | 1 | 2020 | 150 | 0.170 |
Why?
| Neovascularization, Physiologic | 1 | 2000 | 181 | 0.170 |
Why?
| Epigenesis, Genetic | 1 | 2023 | 539 | 0.170 |
Why?
| Pulmonary Artery | 3 | 2021 | 1063 | 0.170 |
Why?
| Catheterization | 4 | 2004 | 163 | 0.170 |
Why?
| AMP-Activated Protein Kinases | 2 | 2023 | 178 | 0.170 |
Why?
| Metabolome | 1 | 2021 | 296 | 0.170 |
Why?
| Flow Cytometry | 2 | 2019 | 1085 | 0.170 |
Why?
| Sirolimus | 2 | 2014 | 195 | 0.160 |
Why?
| Bone Marrow | 2 | 2017 | 255 | 0.160 |
Why?
| Mice, Knockout, ApoE | 1 | 2018 | 9 | 0.160 |
Why?
| Histocompatibility Antigens Class II | 1 | 2020 | 355 | 0.160 |
Why?
| Skin | 1 | 2022 | 657 | 0.160 |
Why?
| Heart Ventricles | 2 | 2021 | 727 | 0.160 |
Why?
| Interleukin-33 | 1 | 2017 | 39 | 0.150 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2019 | 176 | 0.150 |
Why?
| Trans-Activators | 1 | 2020 | 373 | 0.150 |
Why?
| Epithelial Cells | 3 | 2019 | 963 | 0.150 |
Why?
| Receptors, Complement | 1 | 2017 | 115 | 0.150 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 2021 | 702 | 0.150 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 394 | 0.150 |
Why?
| Immunotherapy | 2 | 2018 | 493 | 0.140 |
Why?
| Energy Metabolism | 1 | 2021 | 767 | 0.140 |
Why?
| Ventricular Remodeling | 2 | 2023 | 229 | 0.140 |
Why?
| Gene Deletion | 2 | 2014 | 361 | 0.140 |
Why?
| B7-H1 Antigen | 1 | 2017 | 144 | 0.140 |
Why?
| Cell Cycle Proteins | 1 | 2019 | 565 | 0.140 |
Why?
| Interferon-gamma | 1 | 2019 | 736 | 0.130 |
Why?
| Dinoprostone | 3 | 2016 | 193 | 0.130 |
Why?
| Focal Adhesion Kinase 1 | 3 | 2003 | 28 | 0.130 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2019 | 404 | 0.130 |
Why?
| Aorta | 3 | 2004 | 367 | 0.130 |
Why?
| NF-kappa B | 2 | 2010 | 670 | 0.130 |
Why?
| Interleukin-6 | 3 | 2023 | 688 | 0.130 |
Why?
| Complement Activation | 1 | 2017 | 350 | 0.130 |
Why?
| Retinoid X Receptors | 1 | 2014 | 38 | 0.130 |
Why?
| Pleural Neoplasms | 1 | 2014 | 18 | 0.120 |
Why?
| Culture Media, Serum-Free | 2 | 2004 | 42 | 0.120 |
Why?
| Mesothelioma | 1 | 2014 | 32 | 0.120 |
Why?
| Gene Amplification | 1 | 2014 | 97 | 0.120 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 52 | 0.120 |
Why?
| Autophagy | 2 | 2014 | 315 | 0.120 |
Why?
| Leukotrienes | 1 | 2013 | 35 | 0.120 |
Why?
| Paracrine Communication | 1 | 2014 | 57 | 0.120 |
Why?
| Oligonucleotides, Antisense | 2 | 2004 | 100 | 0.120 |
Why?
| Eicosanoids | 1 | 2013 | 57 | 0.120 |
Why?
| RNA | 1 | 2019 | 833 | 0.120 |
Why?
| Kidney Diseases | 1 | 2017 | 439 | 0.110 |
Why?
| Monocytes | 1 | 2016 | 513 | 0.110 |
Why?
| MAP Kinase Signaling System | 3 | 2021 | 292 | 0.110 |
Why?
| Macrophage Activation | 1 | 2014 | 168 | 0.110 |
Why?
| Iloprost | 2 | 2010 | 46 | 0.110 |
Why?
| Myocardial Contraction | 1 | 2014 | 339 | 0.110 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2014 | 119 | 0.110 |
Why?
| Tumor Burden | 3 | 2020 | 274 | 0.110 |
Why?
| Macrophages, Alveolar | 1 | 2016 | 359 | 0.110 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 589 | 0.110 |
Why?
| Up-Regulation | 2 | 2008 | 872 | 0.110 |
Why?
| Lipocalin-2 | 2 | 2023 | 64 | 0.100 |
Why?
| Immunohistochemistry | 4 | 2021 | 1691 | 0.100 |
Why?
| Heparitin Sulfate | 2 | 2003 | 42 | 0.100 |
Why?
| T-Lymphocytes | 2 | 2017 | 1774 | 0.100 |
Why?
| Protein Processing, Post-Translational | 2 | 2004 | 408 | 0.100 |
Why?
| Splenectomy | 1 | 2011 | 57 | 0.100 |
Why?
| Endothelium, Vascular | 1 | 2018 | 907 | 0.100 |
Why?
| Transforming Growth Factor beta | 1 | 2014 | 462 | 0.100 |
Why?
| Cyclooxygenase 2 | 2 | 2010 | 168 | 0.100 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2012 | 200 | 0.090 |
Why?
| Histone Deacetylases | 1 | 2012 | 198 | 0.090 |
Why?
| Frizzled Receptors | 1 | 2010 | 23 | 0.090 |
Why?
| Green Fluorescent Proteins | 1 | 2011 | 395 | 0.090 |
Why?
| p38 Mitogen-Activated Protein Kinases | 3 | 2015 | 285 | 0.090 |
Why?
| RNA, Small Interfering | 2 | 2010 | 564 | 0.090 |
Why?
| TRPP Cation Channels | 2 | 2019 | 63 | 0.080 |
Why?
| Receptors, Epoprostenol | 1 | 2008 | 6 | 0.080 |
Why?
| Reperfusion Injury | 1 | 2011 | 276 | 0.080 |
Why?
| Lung Injury | 1 | 2011 | 210 | 0.080 |
Why?
| Adenosine Triphosphate | 2 | 2014 | 439 | 0.080 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2010 | 200 | 0.080 |
Why?
| Antineoplastic Agents | 2 | 2017 | 1974 | 0.080 |
Why?
| Glycoproteins | 1 | 2010 | 319 | 0.080 |
Why?
| Severity of Illness Index | 2 | 2013 | 2674 | 0.080 |
Why?
| Receptors, CXCR4 | 1 | 2008 | 81 | 0.080 |
Why?
| Hematopoietic Stem Cells | 1 | 2011 | 359 | 0.080 |
Why?
| Epoprostenol | 1 | 2008 | 132 | 0.080 |
Why?
| Cell Transformation, Neoplastic | 1 | 2010 | 317 | 0.080 |
Why?
| Biomarkers | 4 | 2023 | 3588 | 0.080 |
Why?
| Gene Silencing | 2 | 2019 | 177 | 0.070 |
Why?
| Culture Media, Conditioned | 2 | 2014 | 112 | 0.070 |
Why?
| Neoplasm Metastasis | 1 | 2009 | 544 | 0.070 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 246 | 0.070 |
Why?
| Antihypertensive Agents | 1 | 2010 | 437 | 0.070 |
Why?
| RNA, Messenger | 5 | 2010 | 2657 | 0.070 |
Why?
| Pregnancy | 2 | 2016 | 5691 | 0.070 |
Why?
| Mitogens | 1 | 2005 | 57 | 0.070 |
Why?
| Mutation | 3 | 2023 | 3457 | 0.070 |
Why?
| Neoplasm Transplantation | 2 | 2016 | 245 | 0.070 |
Why?
| Acetylation | 1 | 2006 | 217 | 0.070 |
Why?
| Animals, Genetically Modified | 1 | 2006 | 225 | 0.070 |
Why?
| Protein Subunits | 1 | 2006 | 211 | 0.060 |
Why?
| Gene Knockout Techniques | 2 | 2015 | 105 | 0.060 |
Why?
| Apoptosis | 3 | 2020 | 2484 | 0.060 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 160 | 0.060 |
Why?
| Cell Size | 2 | 2005 | 86 | 0.060 |
Why?
| Chromones | 1 | 2004 | 37 | 0.060 |
Why?
| Enzyme Inhibitors | 2 | 2007 | 827 | 0.060 |
Why?
| Gene Expression Profiling | 3 | 2016 | 1597 | 0.060 |
Why?
| Basement Membrane | 1 | 2003 | 32 | 0.060 |
Why?
| Middle Aged | 3 | 2021 | 27617 | 0.060 |
Why?
| Androstadienes | 1 | 2004 | 94 | 0.060 |
Why?
| Acute-Phase Reaction | 1 | 2023 | 39 | 0.060 |
Why?
| Furosemide | 1 | 2023 | 35 | 0.060 |
Why?
| Embryo, Mammalian | 2 | 2003 | 220 | 0.060 |
Why?
| Tenascin | 1 | 2003 | 13 | 0.060 |
Why?
| Glycosaminoglycans | 1 | 2003 | 78 | 0.060 |
Why?
| Peroxidases | 1 | 2003 | 29 | 0.060 |
Why?
| Peroxidase | 2 | 2015 | 170 | 0.060 |
Why?
| Morpholines | 1 | 2004 | 106 | 0.060 |
Why?
| Fibronectins | 1 | 2003 | 114 | 0.060 |
Why?
| Murinae | 1 | 2022 | 2 | 0.060 |
Why?
| Transfection | 3 | 2014 | 888 | 0.060 |
Why?
| Ileum | 1 | 2023 | 100 | 0.060 |
Why?
| Aniline Compounds | 1 | 2023 | 71 | 0.060 |
Why?
| Aged | 2 | 2018 | 19657 | 0.050 |
Why?
| Coculture Techniques | 2 | 2014 | 208 | 0.050 |
Why?
| Metalloproteases | 1 | 2022 | 38 | 0.050 |
Why?
| Cadherins | 2 | 2016 | 186 | 0.050 |
Why?
| DNA Replication | 1 | 2003 | 211 | 0.050 |
Why?
| Case-Control Studies | 2 | 2021 | 3171 | 0.050 |
Why?
| Matrix Metalloproteinases, Secreted | 1 | 2021 | 10 | 0.050 |
Why?
| Long Term Adverse Effects | 1 | 2021 | 10 | 0.050 |
Why?
| ADAMTS4 Protein | 1 | 2021 | 15 | 0.050 |
Why?
| Cell Line | 2 | 2018 | 2707 | 0.050 |
Why?
| Neoplasms | 1 | 2015 | 2179 | 0.050 |
Why?
| Aorta, Thoracic | 1 | 2003 | 248 | 0.050 |
Why?
| Cellular Microenvironment | 1 | 2021 | 79 | 0.050 |
Why?
| Ventricular Function, Right | 1 | 2023 | 257 | 0.050 |
Why?
| Recombinant Fusion Proteins | 1 | 2003 | 653 | 0.050 |
Why?
| Vasoconstrictor Agents | 1 | 2021 | 122 | 0.050 |
Why?
| Major Histocompatibility Complex | 1 | 2021 | 220 | 0.050 |
Why?
| Leukocytes | 1 | 2021 | 290 | 0.050 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 59 | 0.050 |
Why?
| Butadienes | 1 | 2020 | 33 | 0.050 |
Why?
| Contractile Proteins | 1 | 2000 | 17 | 0.050 |
Why?
| Liver | 2 | 2023 | 1816 | 0.050 |
Why?
| Cell Fusion | 1 | 2000 | 51 | 0.050 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 55 | 0.050 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 2019 | 18 | 0.050 |
Why?
| Thiazolidinediones | 2 | 2011 | 146 | 0.040 |
Why?
| Growth Substances | 1 | 2000 | 136 | 0.040 |
Why?
| Glomerular Filtration Rate | 1 | 2023 | 683 | 0.040 |
Why?
| Genes, Tumor Suppressor | 1 | 2000 | 77 | 0.040 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 348 | 0.040 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2019 | 11 | 0.040 |
Why?
| Pyrimidinones | 1 | 2020 | 86 | 0.040 |
Why?
| Adult | 2 | 2018 | 31512 | 0.040 |
Why?
| Enzyme Activation | 2 | 2014 | 828 | 0.040 |
Why?
| Chemokine CXCL9 | 1 | 2019 | 22 | 0.040 |
Why?
| ErbB Receptors | 1 | 2023 | 569 | 0.040 |
Why?
| Cloning, Molecular | 1 | 2000 | 546 | 0.040 |
Why?
| Nitriles | 1 | 2020 | 155 | 0.040 |
Why?
| Mesoderm | 1 | 2020 | 141 | 0.040 |
Why?
| Tropoelastin | 1 | 1999 | 11 | 0.040 |
Why?
| Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 409 | 0.040 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2019 | 53 | 0.040 |
Why?
| Pyridones | 1 | 2020 | 119 | 0.040 |
Why?
| Luciferases | 2 | 2010 | 143 | 0.040 |
Why?
| Fibroblasts | 1 | 2003 | 842 | 0.040 |
Why?
| Proteoglycans | 1 | 1999 | 109 | 0.040 |
Why?
| Drug Resistance, Neoplasm | 1 | 2023 | 671 | 0.040 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 237 | 0.040 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2003 | 814 | 0.040 |
Why?
| Aortic Valve | 1 | 2022 | 401 | 0.040 |
Why?
| Antibodies, Blocking | 1 | 2017 | 32 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 982 | 0.040 |
Why?
| Complement C3d | 1 | 2017 | 60 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2010 | 874 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2020 | 401 | 0.040 |
Why?
| Complement C3 | 1 | 2017 | 192 | 0.040 |
Why?
| Myocardial Ischemia | 1 | 2018 | 251 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2019 | 356 | 0.040 |
Why?
| Immunoglobulin M | 1 | 2017 | 253 | 0.040 |
Why?
| Arachidonic Acid | 1 | 2016 | 122 | 0.040 |
Why?
| Immunocompetence | 1 | 2016 | 43 | 0.030 |
Why?
| Oncogene Proteins, Fusion | 1 | 2017 | 181 | 0.030 |
Why?
| Lymphocyte Depletion | 1 | 2015 | 119 | 0.030 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 155 | 0.030 |
Why?
| Organ Culture Techniques | 2 | 2007 | 149 | 0.030 |
Why?
| Homozygote | 1 | 2015 | 190 | 0.030 |
Why?
| Kidney Function Tests | 1 | 2015 | 164 | 0.030 |
Why?
| Time Factors | 2 | 2017 | 6412 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 740 | 0.030 |
Why?
| Ventricular Function, Left | 1 | 2018 | 468 | 0.030 |
Why?
| Caspase 3 | 1 | 2015 | 243 | 0.030 |
Why?
| Chemokines | 1 | 2016 | 230 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 333 | 0.030 |
Why?
| Proto-Oncogene Proteins c-sis | 2 | 2005 | 35 | 0.030 |
Why?
| Tetrahydronaphthalenes | 1 | 2014 | 32 | 0.030 |
Why?
| Intracellular Space | 1 | 2014 | 69 | 0.030 |
Why?
| Carcinogenesis | 1 | 2016 | 182 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 462 | 0.030 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 18 | 0.030 |
Why?
| Chemokine CCL2 | 1 | 2014 | 126 | 0.030 |
Why?
| Pyridazines | 1 | 2014 | 50 | 0.030 |
Why?
| Heart | 1 | 2018 | 631 | 0.030 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2014 | 91 | 0.030 |
Why?
| Ventricular Myosins | 1 | 2014 | 33 | 0.030 |
Why?
| Clone Cells | 1 | 2014 | 248 | 0.030 |
Why?
| Superoxides | 1 | 2014 | 221 | 0.030 |
Why?
| Microfilament Proteins | 1 | 2014 | 134 | 0.030 |
Why?
| Cardiomegaly | 1 | 2014 | 168 | 0.030 |
Why?
| Hypoglycemic Agents | 2 | 2011 | 1032 | 0.030 |
Why?
| Integrases | 1 | 2014 | 123 | 0.030 |
Why?
| Imidazoles | 1 | 2014 | 232 | 0.030 |
Why?
| Calcium-Binding Proteins | 1 | 2014 | 217 | 0.030 |
Why?
| Muscle, Skeletal | 1 | 2022 | 1515 | 0.030 |
Why?
| Cardiac Surgical Procedures | 1 | 2017 | 461 | 0.030 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1059 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2016 | 477 | 0.030 |
Why?
| Metabolic Networks and Pathways | 1 | 2013 | 176 | 0.030 |
Why?
| Femoral Artery | 1 | 2014 | 175 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 663 | 0.030 |
Why?
| Capillary Leak Syndrome | 1 | 2011 | 13 | 0.030 |
Why?
| Chemokine CXCL1 | 1 | 2011 | 69 | 0.030 |
Why?
| Benzamides | 1 | 2012 | 176 | 0.020 |
Why?
| Vasoconstriction | 1 | 2012 | 213 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2011 | 410 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 1284 | 0.020 |
Why?
| Cell Lineage | 1 | 2012 | 318 | 0.020 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 193 | 0.020 |
Why?
| Snail Family Transcription Factors | 1 | 2010 | 21 | 0.020 |
Why?
| Regional Blood Flow | 1 | 2012 | 418 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2010 | 83 | 0.020 |
Why?
| Models, Animal | 1 | 2011 | 363 | 0.020 |
Why?
| Spleen | 1 | 2011 | 510 | 0.020 |
Why?
| Matrix Metalloproteinases | 1 | 2010 | 90 | 0.020 |
Why?
| Interleukin-10 | 1 | 2011 | 306 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2011 | 379 | 0.020 |
Why?
| Pyrimidines | 1 | 2012 | 382 | 0.020 |
Why?
| Metabolomics | 1 | 2013 | 550 | 0.020 |
Why?
| Intramolecular Oxidoreductases | 1 | 2008 | 59 | 0.020 |
Why?
| Cell Adhesion | 1 | 2010 | 443 | 0.020 |
Why?
| Myocardium | 1 | 2014 | 970 | 0.020 |
Why?
| Pyridines | 1 | 2012 | 440 | 0.020 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2008 | 111 | 0.020 |
Why?
| Sulindac | 1 | 2007 | 18 | 0.020 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 55 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 2008 | 180 | 0.020 |
Why?
| Prognosis | 1 | 2016 | 3443 | 0.020 |
Why?
| Culture Media | 1 | 2007 | 163 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2007 | 280 | 0.020 |
Why?
| Transgenes | 1 | 2007 | 174 | 0.020 |
Why?
| Neoplasms, Experimental | 1 | 2007 | 158 | 0.020 |
Why?
| Respiratory Mucosa | 1 | 2008 | 254 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2011 | 1171 | 0.020 |
Why?
| Genes, jun | 1 | 2005 | 9 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2005 | 4 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 34 | 0.020 |
Why?
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 16 | 0.020 |
Why?
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2005 | 14 | 0.020 |
Why?
| Blood Pressure | 1 | 2012 | 1664 | 0.020 |
Why?
| Genetic Markers | 1 | 2005 | 348 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2005 | 348 | 0.010 |
Why?
| Heparin Lyase | 1 | 2003 | 4 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 1945 | 0.010 |
Why?
| Genotype | 1 | 2008 | 1882 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 770 | 0.010 |
Why?
| Cattle | 1 | 2004 | 978 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 823 | 0.010 |
Why?
| Binding Sites | 1 | 2003 | 1224 | 0.010 |
Why?
| Homeodomain Proteins | 1 | 2003 | 468 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 1999 | 76 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1999 | 311 | 0.010 |
Why?
| Muscle Development | 1 | 1999 | 102 | 0.010 |
Why?
| Tissue Distribution | 1 | 1999 | 334 | 0.010 |
Why?
| Gestational Age | 1 | 1999 | 765 | 0.010 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 1346 | 0.010 |
Why?
| Models, Biological | 1 | 2003 | 1715 | 0.010 |
Why?
| DNA | 1 | 1999 | 1388 | 0.010 |
Why?
|
|
Weiser-Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|